$0.42
0.48% day before yesterday
Nasdaq, Dec 27, 10:03 pm CET
ISIN
US40423R1059
Symbol
HCWB
Sector
Industry

HCW Biologics Inc Stock price

$0.42
-0.08 16.35% 1M
-0.22 34.39% 6M
-0.81 65.71% YTD
-0.68 61.82% 1Y
-2.05 83.00% 3Y
-5.88 93.33% 5Y
-5.88 93.33% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
+0.00 0.48%
ISIN
US40423R1059
Symbol
HCWB
Sector
Industry

Key metrics

Market capitalization $15.89m
Enterprise Value $27.69m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 7.91
P/S ratio (TTM) P/S ratio 4.54
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 22.27%
Revenue (TTM) Revenue $3.50m
EBIT (operating result TTM) EBIT $-24.45m
Free Cash Flow (TTM) Free Cash Flow $-19.15m
Cash position $1.00m
EPS (TTM) EPS $-1.00
P/E forward negative
P/S forward 1.73
EV/Sales forward 3.02
Short interest 0.04%
Show more

Is HCW Biologics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

HCW Biologics Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast HCW Biologics Inc:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast HCW Biologics Inc:

Buy
100%

Financial data from HCW Biologics Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
3.50 3.50
22% 22%
100%
- Direct Costs 3.14 3.14
4% 4%
90%
0.36 0.36
186% 186%
10%
- Selling and Administrative Expenses 17 17
47% 47%
481%
- Research and Development Expense 7.18 7.18
7% 7%
205%
-24 -24
21% 21%
-676%
- Depreciation and Amortization 0.78 0.78
21% 21%
22%
EBIT (Operating Income) EBIT -24 -24
19% 19%
-698%
Net Profit -37 -37
89% 89%
-1,067%

In millions USD.

Don't miss a Thing! We will send you all news about HCW Biologics Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

HCW Biologics Inc Stock News

Neutral
GlobeNewsWire
6 days ago
Company Expected Notice for Continued Deficiency and Delist Letter from the Nasdaq Stock Market Company Intends to Request Hearing to Appeal in a Timely Manner MIRAMAR, Fla., Dec. 23, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen hea...
Neutral
GlobeNewsWire
about one month ago
MIRAMAR, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today announced that it has entered into a securities purchase agreement with...
Neutral
GlobeNewsWire
about one month ago
HCW Biologics entered into License, Research and Co-Development Agreement with WY Biotech for one of its new proprietary preclinical molecules HCW Biologics to receive upfront payment of $7 million and is eligible to receive additional milestone payments and double-digit royalties on future product sales MIRAMAR, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or “HCW Biologi...
More HCW Biologics Inc News

Company Profile

HCW Biologics, Inc. operates as a holding company which engages in the research and development of immunotherapies. It focuses on cancer and aging-associated diseases. The company was founded by Hing C. Wong on April 2, 2018 and is headquartered in Miramar, FL.

Head office United States
CEO Hing Wong
Employees 45
Founded 2018
Website www.hcwbiologics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today